Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
The Washington Post: Martin Shkreli’s trial shows just how angry people are about drug prices
June 29 Carolyn Y. Johnson Martin Shkreli isn’t actually on trial for buying an obscure antiparasitic drug used by AIDS patients and jacking up the price astronomically, but he might as well be. Three days into Shkreli’s trial for alleged securities fraud — for an issue unrelated to his notorious pharmaceutical price-hike –potential jurors kept […]
News and Reports
AARP: Why Our Drugs Cost So Much
May 2017 AARP Bulletin PRESCRIPTION DRUG PRICES in America are among the highest in the world. On the campaign trail, President Trump said drug companies were “getting away with murder.” Is that true? Or are these firms the beneficiaries of a system that turns a blind eye to excessive profit-making at the expense of society? […]
News and Reports
Marketplace: This cancer patient is devoting his life to making drugs more affordable
May 17 Dan Gorenstein David Mitchell loves to sing. He thought he may spend his retirement with the National Philharmonic chorale. Or maybe head back to school to become a professor. Ultimately, Mitchell decided to use his voice differently. He’s started a national organization, Patients for Affordable Drugs, to channel the public’s growing frustration about […]
News and Reports
The Washington Times: Common-sense remedies for sky-high drug prices
May 14 David Mitchell and Greg Strimple Partisan warfare in Washington never seems to stop. Yet, in poll after poll, Americans want lawmakers to work across the aisle and get things done. The two of us — a professional political strategist and a cancer patient — suggest a bipartisan win for Washington and all Americans. […]
News and Reports
USA Today: Drug makers use co-pay coupons to help mask their rising drug prices
May 3 Jayne O’Donnell Drug maker-funded coupons and patient assistance programs are proving to be an uncertain and often questionable way for patients to afford what a new report shows are increasingly expensive specialty and other brand name drugs. Cumulative spending on drugs that are still under patent is rising at an average annual rate […]
News and Reports
Blood Journal: Next-generation multiple myeloma treatment: a pharmacoeconomic perspective
May 2 Drs. S. Vincent Rajkumar and Jean Luc Harousseau Drs. Vincent Rajkumar and Jean Luc Harousseau are celebrated multiple myeloma doctors. Multiple myeloma is an incurable blood cancer that can be treated with very expensive drugs. Rajkumar and Harousseau explain the impact of high drug prices on patients, and what can be done to […]
News and Reports
The Financial Times: Celgene to Partner Jounce in Battle Against Cancer
May 1 David Crow Celgene, the acquisitive US biotech company, has signed a deal worth up to $2.6bn with a cancer start-up to develop a new generation of drugs that try to turn the body into a weapon against tumours. The partnership with privately owned Jounce Therapeutics is the latest in a flurry of bets […]
News and Reports
Politico Pro: Trump Could Turn to Drug Prices After Obamacare Defeat
March 31 Sarah Karlin-Smith Pharma stayed out of the bruising fight over Obamacare repeal, but the bill’s demise could turn into the industry’s worst nightmare: a big bipartisan fight over drug prices, with President Donald Trump leading the charge. Trump, who has repeatedly promised action on drug prices, is looking for a policy win after […]